🟢 Syncom Formulations is trading 6.2% up; session driver remains unclear

Syncom Formulations is trading at INR 24.66 (+6.20%), but the driver of the October 7 gain remains unclear.

• No clear company-specific announcement dated October 7 explains the rise; recent coverage concerns earlier AGM approvals and director appointments, not a new session catalyst.
• Available sources do not establish broader-market or pharma-sector moves as causes.
• No October 7 trading-volume figure was provided.